×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SGMT – sagimet biosciences inc. - series a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SGMT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
07:03 pm
sgmt
We're Hopeful That Sagimet Biosciences (NASDAQ:SGMT) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That Sagimet Biosciences (NASDAQ:SGMT) Will Use Its Cash Wisely [Yahoo! Finance]
12/19
02:43 pm
sgmt
Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market [Seeking Alpha]
Medium
Report
Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market [Seeking Alpha]
12/18
07:32 am
sgmt
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination [Yahoo! Finance]
Medium
Report
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination [Yahoo! Finance]
12/18
07:00 am
sgmt
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
Medium
Report
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
12/17
07:56 am
sgmt
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet's Fixed Dose Combination Program [Yahoo! Finance]
Low
Report
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet's Fixed Dose Combination Program [Yahoo! Finance]
12/17
07:00 am
sgmt
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
Medium
Report
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
12/10
07:39 am
sgmt
Sagimet's License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China's National Medical Products Administration [Yahoo! Finance]
Low
Report
Sagimet's License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China's National Medical Products Administration [Yahoo! Finance]
12/10
07:03 am
sgmt
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
Low
Report
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
Date
Time
Symbol
Headline
Impact
12/18
04:50 pm
sgmt
Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: KPCB PANDEMIC & BIO DEFENSE FUND LLC
Medium
Report
Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: KPCB PANDEMIC & BIO DEFENSE FUND LLC
12/18
07:06 am
sgmt
Form 8-K Sagimet Biosciences Inc. For: Dec 18
Medium
Report
Form 8-K Sagimet Biosciences Inc. For: Dec 18
12/17
07:06 am
sgmt
Form 8-K Sagimet Biosciences Inc. For: Dec 17
Low
Report
Form 8-K Sagimet Biosciences Inc. For: Dec 17
11/21
06:13 pm
sgmt
Form 4 Sagimet Biosciences Inc. For: Nov 20 Filed by: Kemble George
Low
Report
Form 4 Sagimet Biosciences Inc. For: Nov 20 Filed by: Kemble George
11/20
04:22 pm
sgmt
Form 144 Sagimet Biosciences Inc. Filed by: Kemble George
Medium
Report
Form 144 Sagimet Biosciences Inc. Filed by: Kemble George
11/14
04:21 pm
sgmt
Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: Woodline Partners LP
Low
Report
Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: Woodline Partners LP
11/13
07:36 am
sgmt
Form 8-K Sagimet Biosciences Inc. For: Nov 13
High
Report
Form 8-K Sagimet Biosciences Inc. For: Nov 13
11/13
07:31 am
sgmt
Form 10-Q Sagimet Biosciences Inc. For: Sep 30
High
Report
Form 10-Q Sagimet Biosciences Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: